» Articles » PMID: 30230652

Active Site Flexibility Revealed in Crystal Structures of Parabacteroides Merdae β-glucuronidase from the Human Gut Microbiome

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2018 Sep 20
PMID 30230652
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

β-Glucuronidase (GUS) enzymes in the gastrointestinal tract are involved in maintaining mammalian-microbial symbiosis and can play key roles in drug efficacy and toxicity. Parabacteroides merdae GUS was identified as an abundant mini-Loop 2 (mL2) type GUS enzyme in the Human Microbiome Project gut metagenomic database. Here, we report the crystal structure of P. merdae GUS and highlight the differences between this enzyme and extant structures of gut microbial GUS proteins. We find that P. merdae GUS exhibits a distinct tetrameric quaternary structure and that the mL2 motif traces a unique path within the active site, which also includes two arginines distinctive to this GUS. We observe two states of the P. merdae GUS active site; a loop repositions itself by more than 50 Å to place a functionally-relevant residue into the enzyme's catalytic site. Finally, we find that P. merdae GUS is able to bind to homo and heteropolymers of the polysaccharide alginic acid. Together, these data broaden our understanding of the structural and functional diversity in the GUS family of enzymes present in the human gut microbiome and point to specialization as an important feature of microbial GUS orthologs.

Citing Articles

Catabolism of Polysaccharide and Its Impacts on Gut Microbial Composition during In Vitro Digestion and Microbial Fermentation.

Zhao Y, Huang L, Wu D, Li J, Lei J, Fu M Foods. 2023; 12(9).

PMID: 37174446 PMC: 10178076. DOI: 10.3390/foods12091909.


Characterizing the metabolic effects of the selective inhibition of gut microbial β-glucuronidases in mice.

Letertre M, Bhatt A, Harvey M, Nicholson J, Wilson I, Redinbo M Sci Rep. 2022; 12(1):17435.

PMID: 36261446 PMC: 9581996. DOI: 10.1038/s41598-022-21518-4.


A structural metagenomics pipeline for examining the gut microbiome.

Walker M, Simpson J, Redinbo M Curr Opin Struct Biol. 2022; 75:102416.

PMID: 35841748 PMC: 10039758. DOI: 10.1016/j.sbi.2022.102416.


The role of gut microbial β-glucuronidase in drug disposition and development.

Gao S, Sun R, Singh R, So S, Chan C, Savidge T Drug Discov Today. 2022; 27(10):103316.

PMID: 35820618 PMC: 9717552. DOI: 10.1016/j.drudis.2022.07.001.


Functional metagenomic screening identifies an unexpected β-glucuronidase.

Neun S, Brear P, Campbell E, Tryfona T, El Omari K, Wagner A Nat Chem Biol. 2022; 18(10):1096-1103.

PMID: 35799064 DOI: 10.1038/s41589-022-01071-x.


References
1.
Pollet R, DAgostino E, Walton W, Xu Y, Little M, Biernat K . An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. Structure. 2017; 25(7):967-977.e5. PMC: 5533298. DOI: 10.1016/j.str.2017.05.003. View

2.
Wallace B, Roberts A, Pollet R, Ingle J, Biernat K, Pellock S . Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. Chem Biol. 2015; 22(9):1238-49. PMC: 4575908. DOI: 10.1016/j.chembiol.2015.08.005. View

3.
Malfatti M, Felton J . Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Chem Res Toxicol. 2004; 17(8):1137-44. DOI: 10.1021/tx049898m. View

4.
Malfatti M, Ubick E, Felton J . The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo. Carcinogenesis. 2005; 26(11):2019-28. DOI: 10.1093/carcin/bgi151. View

5.
Pellock S, Redinbo M . Glucuronides in the gut: Sugar-driven symbioses between microbe and host. J Biol Chem. 2017; 292(21):8569-8576. PMC: 5448086. DOI: 10.1074/jbc.R116.767434. View